This company has been marked as potentially delisted and may not be actively trading. Roivant Sciences (ROIVW) News Today Add Share Share Headlines Stock AnalysisBuy This Stock ROIVW Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Roivant Sciences Earnings Call: Progress Amid ChallengesAugust 13, 2025 | msn.comRoivant Sciences Reports Q1 2025 Financial ResultsAugust 12, 2025 | msn.comA Glimpse of Roivant Sciences's Earnings PotentialAugust 8, 2025 | benzinga.comROIV Roivant Sciences Ltd. - Seeking AlphaJune 27, 2025 | seekingalpha.comRoivant Sciences Ltd (ROIV) Q4 2024 Earnings Call Highlights: Strong Financial Position and ...May 30, 2025 | finance.yahoo.com4ROIV : Roivant Sciences's Earnings OutlookMay 28, 2025 | benzinga.comIs Roivant Sciences (ROIV) the Best Mid Cap Biotech Stock to Buy?March 29, 2025 | msn.comRoivant Sciences president Eric Venker sells over $4.56 million in stockFebruary 14, 2025 | msn.comNews Flash: Analysts Just Made A Captivating Upgrade To Their Roivant Sciences Ltd. (NASDAQ:ROIV) ForecastsFebruary 12, 2025 | finance.yahoo.comRoivant Sciences Ltd. (ROIV): A Cheap Biotech Stock to Invest In NowFebruary 12, 2025 | msn.comRoivant: Telavant-Like Success Will Be Challenging To Replicate (Rating Downgrade)February 5, 2025 | seekingalpha.comRoivant sciences president Eric Venker sells $1.13 million in sharesJanuary 22, 2025 | msn.comBank of America Securities Reaffirms Their Hold Rating on Roivant Sciences (ROIV)January 14, 2025 | markets.businessinsider.comStrategic Sale: Eric Venker Decides To Exercise Options Worth $3.86M At Roivant SciencesJanuary 1, 2025 | benzinga.comOptimistic Outlook on Roivant Sciences Despite Namilumab SetbackDecember 6, 2024 | markets.businessinsider.comSeveral Positive Developments Lifted Roivant (ROIV) in Q3December 6, 2024 | msn.comThe Analyst Landscape: 5 Takes On Roivant SciencesNovember 14, 2024 | benzinga.comRoivant Sciences Reports Q2 2024 Financial ResultsNovember 14, 2024 | markets.businessinsider.comRoivant Sciences Ltd. (NASDAQ:ROIV) Q2 2024 Earnings Call TranscriptNovember 14, 2024 | msn.comRoivant Sciences Ltd (ROIV) Q2 2024 Earnings Call Highlights: Strong Cash Position and ...November 13, 2024 | finance.yahoo.comRoivant Sciences Ltd. (ROIV): Among the Most Promising Mid-Cap Stocks According to Hedge FundsOctober 14, 2024 | msn.comIs Roivant Sciences Ltd. (NASDAQ:ROIV) The Best NASDAQ Stock Under $20?October 8, 2024 | msn.comIs Roivant Sciences Ltd. (NASDAQ:ROIV) The Best NASDAQ Stock Under $50 To Buy?September 30, 2024 | finance.yahoo.comROIV Roivant Sciences Ltd.September 28, 2024 | seekingalpha.comQVT Financial LP Adjusts Stake in Roivant Sciences LtdSeptember 27, 2024 | finance.yahoo.comIs Roivant Sciences Ltd. (ROIV) the Best Guru Stock To Buy Now?September 25, 2024 | msn.comRoivant Sciences maintains buy rating by H.C. WainwrightSeptember 21, 2024 | uk.investing.comAnalysts Offer Insights on Healthcare Companies: Progyny (PGNY) and Roivant Sciences (ROIV)September 19, 2024 | markets.businessinsider.comPromising Outlook for Roivant Sciences’ Mosliciguat in Treating PH-ILD: An Analytical PerspectiveSeptember 13, 2024 | markets.businessinsider.comMosliciguat for PH-ILD: A Cautious Hold Rating Amidst Promising Phase 1 ResultsSeptember 11, 2024 | markets.businessinsider.comRoivant Provides Update on Graves’ Disease Development ProgramSeptember 9, 2024 | markets.businessinsider.comRoivant Sciences Ltd (87S.DU)August 23, 2024 | sg.finance.yahoo.comShareholders In Roivant Sciences (NASDAQ:ROIV) Should Look Beyond Earnings For The Full StoryAugust 22, 2024 | finance.yahoo.comBuy Rating Affirmed on Roivant Sciences Ahead of Revealing High-Potential Phase 2 Asset and Promising Pipeline MilestonesAugust 14, 2024 | markets.businessinsider.comBalancing Act: Hold Recommendation Amidst Roivant Sciences’ Sales Shortfalls and Promising Pipeline PotentialAugust 9, 2024 | markets.businessinsider.comRoivant Sciences Ltd. (ROIV) Q1 2025 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.com3 Best Stocks to Buy Now, 7/19/2024, According to Top AnalystsJuly 20, 2024 | msn.comPiper Sandler Keeps Their Buy Rating on Roivant Sciences (ROIV)July 19, 2024 | markets.businessinsider.comInstitutional Investors are Betting on Roivant Sciences (NASDAQ:ROIV)May 27, 2024 | msn.comInstitutional investors are Roivant Sciences Ltd.'s (NASDAQ:ROIV) biggest bettors and were rewarded after last week's US$290m market cap gainMay 5, 2024 | finance.yahoo.comBuy Rating Justified by Roivant Sciences’ Strategic Positioning and Promising Drug PipelineMay 2, 2024 | markets.businessinsider.comCritical Insights From Roivant Sciences Analyst Ratings: What You Need To KnowApril 22, 2024 | markets.businessinsider.comBuy Rating Affirmed for Roivant Sciences Amid Brepocitinib Success and Strategic Share Repurchase ProgramApril 3, 2024 | markets.businessinsider.comStocks Fall as Bond Yields Climb on Strong US Economic NewsApril 2, 2024 | msn.comRoivant Reports Positive NEPTUNE Study Results; Approves Share Repurchase For Up To $1.5 BlnApril 2, 2024 | markets.businessinsider.comVivek Ramaswamy-Founded Roivant's Anti-Inflammatory Drug Aces Mid-Stage StudyApril 2, 2024 | msn.comTech Stocks Pressured by NvidiaMarch 28, 2024 | theglobeandmail.comStocks Push Higher as T-note Yields SlipMarch 28, 2024 | msn.comRoche to Buy Telavant for $7.1 BillionMarch 12, 2024 | msn.comRoivant Sciences (Nasdaq:ROIVW) HeadlineTrading was temporarily halted for "ROIVW" at 04:09 PM with a stated reason of "News pending."...September 1, 2023 | marketbeat.com Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIVW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ROIVW Media Mentions By Week ROIVW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ROIVW News Sentiment▼0.001.34▲Average News Sentiment ROIVW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ROIVW Articles This Week▼00▲ROIVW Articles Average Week Get the Latest News and Ratings for ROIVW and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Roivant Sciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ROIVW) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roivant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access